Providencia infections

Suggested Alternatives for Differential Diagnosis Enterobacter infections, enterococcal infections, klebsiella infections, proteus infections, providencia infections, Pseudomonas aeruginosa infections, serratia, shigellosis, and streptococcus group B infections. 

Suggested Alternatives for Differential Diagnosis Infections from other bacteria such as Enterobacter, E. coli, Klebsiella, Proteus, and Providencia, producing meningitis, pneumonia, or sepsis. 

Nosocomial UTI is the most common infection in hospitals and nursing homes and 80% is associated with the use of urethral catheters. An incidence of bacteriuria of 3-10%/day makes the duration of catheterization the most important risk factor for bacteriuria. Asymptomatic bacteriuria should not be treated. However, up to 30% of patients with catheter-associated bacteriuria will develop fevers or other symptoms of UTI. In long term catheterization Providencia stmrtii and Candida species are the most common responsible organisms. Exchange of the catheter under therapy is advised in chronic cases. 

Carbenicillin is indicated in the treatment of acute and chronic infections of the upper and lower urinary tract and in asymptomatic bacteriuria due to susceptible strains of Escherichia coli, Proteus mirabilis, Morganella morganii, Providencia rettgeri, P. vulgaris, Pseudomonas, Entero-bacter, and enterococci. It is also indicated in the treatment of prostatitis due to susceptible strains of E. coli, enterococcus (S. faecalis), P. mirabilis, and Enterobacter species. 

Skin and skin structure infections caused by susceptible S. faecalis (enterococcus), E. coli, P. mirabilis, the indole-positive Proteus sp., P. vulgaris, and Providencia rettgeri, Klebsiella sp., Enterobacter sp.. Pseudomonas sp., Peptococcus sp., and Bacteroides sp. 

Complicated and recurrent urinary tract infections (UTIs) caused by P. aeruginosa, Proteus sp. (indole-positive and indole-negative), E. coli, Klebsiella sp., Enterobacter sp., Serratia sp., S. aureus, Providencia sp., and Citrobacter sp., the drug is not indicated in uncomplicated initial episodes of UTIs unless the organisms are not susceptible to less toxic antibiotics... 

---